The Case for Combination Therapy as First-Line Treatment for the Type 2 Diabetic Patient
Prospects for the Development of Long-Acting Formulations of Human Somatropin
Progress in Islet Transplantation in Patients with Type 1 Diabetes Mellitus
Somatropin Therapy and Cognitive Function in Adults with Growth Hormone Deficiency
Thiazolidinediones for the Therapeutic Management of Polycystic Ovary Syndrome
Spotlight on Pioglitazone in Type 2 Diabetes Mellitus1
Opinion and Evidence for Treatments in Endocrine Disorders